Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ROS1 Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm.
Marchetti A, Barberis M, Di Lorito A, Pace MV, Di Lisio C, Felicioni L, Guerini-Rocco E, Vingiani A, D'Antuono T, Liberatore M, Filice G, De Luca G, De Marinis F, Passaro A, Guetti L, Irtelli L, Crinò L, Mucilli F, Buttitta F. Marchetti A, et al. Among authors: felicioni l. JCO Precis Oncol. 2017 Nov;1:1-9. doi: 10.1200/PO.16.00010. JCO Precis Oncol. 2017. PMID: 35172481
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma.
Buttitta F, Pellegrini C, Marchetti A, Gadducci A, Cosio S, Felicioni L, Barassi F, Salvatore S, Martella C, Coggi G, Bosari S. Buttitta F, et al. Among authors: felicioni l. J Clin Oncol. 2003 Apr 1;21(7):1320-5. doi: 10.1200/JCO.2003.09.065. J Clin Oncol. 2003. PMID: 12663721
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.
Marchetti A, Martella C, Felicioni L, Barassi F, Salvatore S, Chella A, Camplese PP, Iarussi T, Mucilli F, Mezzetti A, Cuccurullo F, Sacco R, Buttitta F. Marchetti A, et al. Among authors: felicioni l. J Clin Oncol. 2005 Feb 1;23(4):857-65. doi: 10.1200/JCO.2005.08.043. J Clin Oncol. 2005. PMID: 15681531
Int6 expression can predict survival in early-stage non-small cell lung cancer patients.
Buttitta F, Martella C, Barassi F, Felicioni L, Salvatore S, Rosini S, D'Antuono T, Chella A, Mucilli F, Sacco R, Mezzetti A, Cuccurullo F, Callahan R, Marchetti A. Buttitta F, et al. Among authors: felicioni l. Clin Cancer Res. 2005 May 1;11(9):3198-204. doi: 10.1158/1078-0432.CCR-04-2308. Clin Cancer Res. 2005. PMID: 15867213
Assessing EGFR mutations.
Marchetti A, Felicioni L, Buttitta F. Marchetti A, et al. Among authors: felicioni l. N Engl J Med. 2006 Feb 2;354(5):526-8; author reply 526-8. doi: 10.1056/NEJMc052564. N Engl J Med. 2006. PMID: 16452569 No abstract available.
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features.
Buttitta F, Barassi F, Fresu G, Felicioni L, Chella A, Paolizzi D, Lattanzio G, Salvatore S, Camplese PP, Rosini S, Iarussi T, Mucilli F, Sacco R, Mezzetti A, Marchetti A. Buttitta F, et al. Among authors: felicioni l. Int J Cancer. 2006 Dec 1;119(11):2586-91. doi: 10.1002/ijc.22143. Int J Cancer. 2006. PMID: 16988931 Free article.
49 results